Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila(University of South Florida), Renier J. Brentjens(Roswell Park Comprehensive Cancer Center), Qing He(Memorial Sloan Kettering Cancer Center), Hilda Quintanilla(Memorial Sloan Kettering Cancer Center), Stephen S. Chung(Memorial Sloan Kettering Cancer Center), Mark Satter(Memorial Sloan Kettering Cancer Center), Mitsú J. Fink(Memorial Sloan Kettering Cancer Center), Himaly Shinglot(Memorial Sloan Kettering Cancer Center), Isabelle Rivière(Memorial Sloan Kettering Cancer Center), Teresa Wasielewska(Memorial Sloan Kettering Cancer Center), James Hosey(Unknown), Mithat Gönen(Memorial Sloan Kettering Cancer Center), Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Diana Bouhassira(Memorial Sloan Kettering Cancer Center), Maher Youssif(Memorial Sloan Kettering Cancer Center), Michel Sadelain(Columbia University Irving Medical Center), Jinrong Qu(Memorial Sloan Kettering Cancer Center), Yongzeng Wang(Memorial Sloan Kettering Cancer Center), Shirley Bartido(Memorial Sloan Kettering Cancer Center), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Malgorzata Olszewska(Memorial Sloan Kettering Cancer Center), Elizabeth Halton(Memorial Sloan Kettering Cancer Center), P. Maslak(Memorial Sloan Kettering Cancer Center), Oriana Bórquez-Ojeda(Unknown), Xiuyan Wang(Tongji University), Jae H. Park(Memorial Sloan Kettering Cancer Center), Jolanta Stefanski(Memorial Sloan Kettering Cancer Center), Mark G. Frattini(Presbyterian Hospital), Yvette Bernal(Memorial Sloan Kettering Cancer Center), Dan Douer(Memorial Sloan Kettering Cancer Center), Gail J. Roboz(Cornell University)
Cited by 2,495
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
|Nature Reviews Clinical Oncology|2019|1.4k